Ribozyme-mediated inhibition of rat leukocyte-type 12-lipoxygenase prevents intimal hyperplasia in balloon-injured rat carotid arteries

Circulation

Volumn 103, Issue 10, 2001, Pages 1446-1452

  Gu, Jia Li ^b   Pei, Hong ^b   Thomas, Lisa ^c   Nadler, Jerry L ^b,d   Rossi, John J ^a   Lanting, Linda ^a   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Growth substances; Lipids; Restenosis; Vasculature

Indexed keywords

ARACHIDONIC ACID; GROWTH PROMOTOR; LIPOFECTIN; MESSENGER RNA; RIBOZYME;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CAROTID ARTERY; CATALYSIS; CHEMOTAXIS; CONTROLLED STUDY; DNA RNA HYBRIDIZATION; ENZYME INHIBITION; LEUKOCYTE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 0035853069     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.10.1446     Document Type: Article

References (31)

1. Restenosis after coronary, angioplasty: An overview
2. The pathogenesis of atherosclerosis: A perspective for the 1990's
3. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia
4. Crosstalk among multiple signal-activated phospholipases
5. "Enzymatic" lipid peroxidation: Reactions of mammalian lipoxygenases
6. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions
7. Angiotensin II. Growth factors and lipoxygenase
8. The molecular biology of mammalian lipoxygenases and quest for eicosanoid functions using lipoxygenase-deficient mice
9. Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells
10. A leukocyte-type 12-lipoxygenase is expressed in human vascular and mononuclear cells: Evidence for upregulation by angiotensin II
11. Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes
12. Molecular cloning of a 12-lipoxygenase cDNA from rat brain
13. Specific inflammatory, cytokines regulate the expression of human monocyte 15-lipoxygenase
14. Induction of 15-lipoxygenase by IL-13 in human blood monocytes
15. Platelet-derived growth factor BB mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells
16. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy
17. Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells
18. Evidence of 12-lipoxygenase expression in balloon injured rat carotid arteries
19. Biological catalysis by RNA
20. Therapeutic ribozymes: Principles and applications
21. RNA-enzyme-directed gene therapy
22. Ribozyme-mediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells
23. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling intracellular localization
24. Use of a hammerhead ribozyme with cationic liposomes to reduce leukocyte-type 12-lipoxygenase expression in vascular smooth muscle
25. Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo
26. Numbering system for the hammerhead
27. High activity and stability of hammerhead ribozymes containing 2′-modified pyrimidine nucleosides and phosphorothiates
28. Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells
29. Chimeric DNA-RNA hammerhead ribozyme to PCNA reduces stent-induced stenosis in a porcine coronary model
30. Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo
31. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice